HAMED KAMAL (Chief Medical Officer) sold 6.4% of their position (39.50K shares) of SPERO THERAPEUTICS, INC. on the open market
Open‑market sale worth $50.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/15/2023ACC: 0000950170-23-048440
Officer· Chief Medical Officer
Since Sep 2022
-39.50K
Net shares
Net seller
$50.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
39.50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−39.50K
Price / share
$1.27
Trade value
$50.16K
% of position
6.4%
9/13/2023
615.96K→576.46K
Total
Net shares
−39.50K
Net value
-$50.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/13/2023 | S · Sale | −39.50K | $1.27 | $50.16K | 6.4% | 615.96K | 576.46K |
| Total | −39.50K | -$50.16K | ||||||
Derivative Transactions0
No derivative transactions reported